Peptilogics Revenue and Competitors
Estimated Revenue & Valuation
- Peptilogics's estimated annual revenue is currently $2.6M per year.
- Peptilogics's estimated revenue per employee is $91,000
Employee Data
- Peptilogics has 29 Employees.
- Peptilogics grew their employee count by -24% last year.
Peptilogics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder | President | CEO | Reveal Email/Phone |
2 | Sr. VP, Regulatory Affairs and Quality | Reveal Email/Phone |
3 | VP, CMC and Technical Operations | Reveal Email/Phone |
4 | SVP, Corporate Operations and Finance | Reveal Email/Phone |
5 | VP People | Reveal Email/Phone |
6 | VP, CMC and Technical Operations | Reveal Email/Phone |
7 | SVP Corporate Affairs & Patient Advocacy | Reveal Email/Phone |
8 | VP Program Development | Reveal Email/Phone |
9 | Chief Medical Officer | Reveal Email/Phone |
10 | Director, Nonclinical Development | Reveal Email/Phone |
Peptilogics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.7M | 45 | 7% | N/A | N/A |
#2 | $77.2M | 475 | 7% | N/A | N/A |
#3 | $9.9M | 76 | 0% | N/A | N/A |
#4 | $10.5M | 81 | 40% | N/A | N/A |
#5 | $0.9M | 12 | 0% | N/A | N/A |
#6 | $0.1M | 8 | -11% | $21.3M | N/A |
#7 | $20.2M | 141 | -27% | N/A | N/A |
#8 | $11.1M | 85 | -13% | $5.3M | N/A |
#9 | $4.6M | 44 | -4% | N/A | N/A |
#10 | $1M | 13 | N/A | N/A | N/A |
What Is Peptilogics?
Peptilogics is a clinical-stage biotechnology company that designs and develops novel peptide therapeutics. Through their computational platform, Peptilogics is radically altering drug discovery by not only uncovering new, previously unexplored chemical design space, but ensuring that each potential therapeutic is biologically viable and scalable to manufacture. Peptilogics' lead clinical stage peptide therapeutic, PLG0206, is a novel, broad-spectrum anti-infective that has been granted FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation for its initial focus on the treatment of prosthetic joint infections, an unmet medical need.
keywords:N/A
N/A
Total Funding
29
Number of Employees
$2.6M
Revenue (est)
-24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Peptilogics News
Peptilogics to Present Data Highlighting Designed Antimicrobial Peptide for the Treatment of Periprosthetic Joint Infection (PJI) at ECCMID...
Peptilogics' research finds that PLG0206 is able to tackle gram-positive and gram-negative pathogens as a bactericidal, broad-spectrum treatment...
Other Companies in Pittsburgh
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.9M | 29 | -3% | N/A |
#2 | $3.3M | 29 | 7% | N/A |
#3 | $5.9M | 29 | 12% | N/A |
#4 | $2.9M | 29 | 4% | N/A |
#5 | $2.9M | 29 | 32% | N/A |